|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Boeree, Martin J.; Heinrich, Norbert; Aarnoutse, Rob; Diacon, Andreas H.; Dawson, Rodney; Rehal, Sunita; Kibiki, Gibson S.; Churchyard, Gavin; Sanne, Ian; Ntinginya, Nyanda E.; Minja, Lilian T.; Hunt, Robert D.; Charalambous, Salome; Hanekom, Madeleine; Semvua, Hadija H.; Mpagama, Stellah G.; Manyama, Christina; Mtafya, Bariki; Reither, Klaus; Wallis, Robert S.; Venter, Amour; Narunsky, Kim; Mekota, Anka; Henne, Sonja; Colbers, Angela; Plemper van Balen, Georgette; Gillespie, Stephen H.; Phillips, Patrick P. J. und Hölscher, Michael
(2017):
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
In: Lancet infectious Diseases, Bd. 17, Nr. 1: S. 39-49
Wallis, Robert S.; Maeurer, Markus; Mwaba, Peter; Chakaya, Jeremiah; Rustomjee, Roxana; Migliori, Giovanni Battista; Marais, Ben; Schito, Marco; Churchyard, Gavin; Swaminathan, Soumya; Hölscher, Michael und Zumla, Alimuddin
(2016):
Tuberculosis - advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.
In: Lancet infectious Diseases, Bd. 16, Nr. 4, E34-E46
Zumla, Alimuddin; Rao, Martin; Wallis, Robert S.; Kaufmann, Stefan H. E.; Rustomjee, Roxana; Mwaba, Peter; Vilaplana, Cris; Yeboah-Manu, Dorothy; Chakaya, Jeremiah; Ippolito, Giuseppe; Azhar, Esam; Hölscher, Michael und Maeurer, Markus
(2016):
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects.
In: Lancet infectious Diseases, Bd. 16, Nr. 4, E47-E63
Zumla, Alimuddin; Schito, Marco; Chakaya, Jeremiah; Marais, Ben; Mwaba, Peter; Migliori, Giovanni Battista; Hölscher, Michael; Maeurer, Markus und Wallis, Robert S.
(2016):
World TB Day 2016: reflections on the global TB emergency.
In: Lancet Respiratory Medicine, Bd. 4, Nr. 4: S. 249-251